You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Corrigendum to “Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma”

Journal of International Medical Research

Impact Factor: 1.5 / 5-Year Impact Factor: 1.7

Journal Homepage Submission guidelines

Open access

Correction

First published online February, 2024

Corrigendum to “Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma”

All Articles

https://doi.org/10.1177/03000605241230417

Abstract

Zou J, Zhang K, Zhu J, et al. Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma. Journal of International Medical Research 2024; 52(1). DOI: 10.1177/03000605231218559

The first author’s name was incorrectly mentioned in the article as “Jingjng Zou”.

The correct author name should be “Jingjing Zou”.

The article has been corrected.